Serologic evaluation of Hepatitis B vaccination (Infanrix hexa)
Completed
- Conditions
- immunological response antibodies10019815
- Registration Number
- NL-OMON31015
- Lead Sponsor
- RIVM
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 300
Inclusion Criteria
Children vaccinated with the combination vaccin Infanrix hexa, of which hepatitis B is a part
Exclusion Criteria
Children not vaccinated with the combination vaccine Infanrix hexa and children born to women with hepatitis B infection will be excluded.
Study & Design
- Study Type
- Observational invasive
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method